What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us About the Pathogenesis of Type 2 Diabetes?

被引：9
作者：
Adams, J. D. [1 ]
Vella, Adrian [1 ]
机构：
[1] Mayo Clin, Coll Med, Endocrine Res Unit, Dept Endocrinol Diabet & Nutr, 200 First St SW,Rm 5-194 Joseph, Rochester, MN 55905 USA
来源：
METABOLIC SYNDROME AND RELATED DISORDERS | 2018年 / 16卷 / 08期
基金：
美国国家卫生研究院;
关键词：
common genetic variation; insulin secretion; insulin action; type; 2; diabetes; PATHWAY EFFECTOR TCF7L2; INSULIN-SECRETION; BETA-CATENIN; SUSCEPTIBILITY GENE; GLUCOSE-METABOLISM; PROGLUCAGON GENE; CELL FUNCTION; WNT; POLYMORPHISMS; EXPRESSION;
D O I：
10.1089/met.2018.0024
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Type 2 diabetes mellitus (T2DM) is a polygenic metabolic disorder characterized by hyperglycemia occurring as a result of impaired insulin secretion and/or insulin resistance. Among the various genetic factors associated with T2DM, a common genetic variant within the transcription factor 7-like 2 locus (TCF7L2) confers the greatest genetic risk for development of the disease. However, the mechanism(s) by which TCF7L2 predisposes to diabetes remain uncertain. Here we review the current literature pertaining to the potential mechanisms by which TCF7L2 confers risk of T2DM, using genetic variation as a probe to understand the pathogenesis of the disease.
引用
收藏
页码：383 / 389
页数：7
相关论文
共 50 条
  • [21] Worldwide Distribution of Type II Diabetes-Associated TCF7L2 SNPs: Evidence for Stratification in Europe
    Guinan, Kieran J.
    BIOCHEMICAL GENETICS, 2012, 50 (3-4) : 159 - 179
  • [22] The new type 2 diabetes gene TCF7L2
    Florez, Jose C.
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2007, 10 (04) : 391 - 396
  • [23] TCF7L2 polymorphisms are associated with type 2 diabetes in Khatri Sikhs from North India:: Genetic variation affects lipid levels
    Sanghera, D. K.
    Nath, S. K.
    Ortega, L.
    Gambarelli, M.
    Kim-Howard, X.
    Singh, J. R.
    Ralhan, S. K.
    Wander, G. S.
    Mehra, N. K.
    Mulvihill, J. J.
    Kamboh, M. I.
    ANNALS OF HUMAN GENETICS, 2008, 72 : 499 - 509
  • [24] Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City
    Parra, E. J.
    Cameron, E.
    Simmonds, L.
    Valladares, A.
    McKeigue, P.
    Shriver, M.
    Wacher, N.
    Kumate, J.
    Kittles, R.
    Cruz, M.
    CLINICAL GENETICS, 2007, 71 (04) : 359 - 366
  • [25] The involvement of the wnt signaling pathway and TCF7L2 in diabetes mellitus: The current understanding, dispute, and perspective
    Ip, Wilfred
    Chiang, Yu-ting Alex
    Jin, Tianru
    CELL AND BIOSCIENCE, 2012, 2
  • [26] TCF7L2 is associated with type 2 diabetes in nonobese individuals from Tunisia
    Bouhaha, R.
    Choquet, H.
    Meyre, D.
    Kamoun, H. Abid
    Ennafaa, H.
    Baroudi, T.
    Sassi, R.
    Vaxillaire, M.
    Elgaaied, A.
    Froguel, P.
    Cauchi, S.
    PATHOLOGIE BIOLOGIE, 2010, 58 (06): : 426 - 429
  • [27] Novel TCF7L2 familial linkage and association with Type 2 diabetes, depression, and their comorbidity
    Del Bosque-plata, L.
    Amin, M.
    Wu, R.
    Postolache, T. T.
    Gragnoli, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (02) : 694 - 703
  • [28] TCF7L2 and type 2 diabetes—we WNT to know
    U. Smith
    Diabetologia, 2007, 50 : 5 - 7
  • [29] TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden
    Mayans, Sofia
    Lackovic, Kurt
    Lindgren, Petter
    Ruikka, Karin
    Agren, Asa
    Eliasson, Mats
    Holmberg, Dan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2007, 15 (03) : 342 - 346
  • [30] TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden
    Sofia Mayans
    Kurt Lackovic
    Petter Lindgren
    Karin Ruikka
    Åsa Ågren
    Mats Eliasson
    Dan Holmberg
    European Journal of Human Genetics, 2007, 15 : 342 - 346
12345